We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

44 hedge funds and large institutions have $41.6M invested in Marrone Bio Innovations, Inc. in 2018 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 5

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

83% more funds holding

Funds holding: 24 → 44 (+20)

39% less capital invested

Capital invested by funds: $68.1M → $41.6M (-$26.6M)

Holders
44
Holders Change
+20
Holders Change %
+83.33%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
9
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$4.87M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.25M
3
State Street
State Street
Massachusetts
+$1.48M
4
Northern Trust
Northern Trust
Illinois
+$894K
5
IAM
ICM Asset Management
Washington
+$465K

Top Sellers

Rank Fund Capital Flow
1
WRF
Waddell & Reed Financial
Kansas
-$37.2M
2
CPA
Capital Planning Advisors
California
-$66K
3
LWAC
Laurel Wealth Advisors (California)
California
-$40K
4
GC
Guggenheim Capital
Illinois
-$36K
5
Barclays
Barclays
United Kingdom
-$30.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Credit Suisse
Switzerland
$26K +$26.2K +14,054 New
AF
27
Allworth Financial
California
$23K +$5.15K +2,766 +28%
RJFSA
28
Raymond James Financial Services Advisors
Florida
$20K – – –
Citigroup
29
Citigroup
New York
$20K +$20.1K +10,778 New
JP Morgan Chase
30
JP Morgan Chase
New York
$20K +$20.6K +11,078 New
Bank of America
31
Bank of America
North Carolina
$19K +$290 +156 +2%
Legal & General Group
32
Legal & General Group
United Kingdom
$15K +$15.1K +8,134 New
UBS Group
33
UBS Group
Switzerland
$12K +$6.63K +3,562 +127%
AIP
34
Ameritas Investment Partners
Nebraska
$9K +$9.17K +4,928 New
Barclays
35
Barclays
United Kingdom
$7K -$30.1K -16,196 -80%
GBBWRPM
36
Genovese Burford & Brothers Wealth & Retirement Plan Management
California
$6K – – –
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$3.28K +$3.32K +1,785 New
CFA
38
Carroll Financial Associates
North Carolina
$3K – – –
LTFS
39
Ladenburg Thalmann Financial Services
Florida
$2K – – –
PIA
40
Piedmont Investment Advisors
North Carolina
$2K +$1.76K +947 New
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$1K +$722 +388 New
MAM
42
Meeder Asset Management
Ohio
$964 +$975 +524 New
FDCDDQ
43
Federation des caisses Desjardins du Quebec
Quebec, Canada
$920 – – –
CPA
44
Capital Planning Advisors
California
– -$66K -33,079 Closed
LWAC
45
Laurel Wealth Advisors (California)
California
– -$40K -20,000 Closed
GC
46
Guggenheim Capital
Illinois
– -$36K -17,851 Closed
BCM
47
BlueCrest Capital Management
Jersey
– -$25K -12,428 Closed
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
– +$115 +62 New
1
2

MBII Hedge Fund Activity: Q2 2018 in Review

44 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2018, worth a combined $41.6M — down 39% from $68.1M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MBII positions and 5 closed out — a net gain of 20 holders — while 9 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, adding an estimated $4.87M. The largest seller was Waddell & Reed Financial, cutting an estimated $37.2M.

  • 44 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2018, up from 24 in Q1 2018.
  • Funds reported $41.6M of Marrone Bio Innovations, Inc. stock for Q2 2018, down 39% quarter-over-quarter.
  • 25 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2018 and 5 closed out, a net change of +20 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q2 2018 was BlackRock, an estimated $4.87M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q2 2018 was Waddell & Reed Financial, an estimated $37.2M sold.

Based on aggregated 13F filings for Q2 2018.